Accidental discovery of a 'longer-range' vinylogous Pummerer-type lactonization: Formation of sulindac sulfide lactone from sulindac

Tetrahedron Letters

Volumn 52, Issue 11, 2011, Pages 1179-1182

  Halder, Somnath ^a   Satyam, Apparao ^a  

^a Piramal Enterprises Limited   (India)

Author keywords

Longer range vinylogous Pummerer type lactonization; Sulindac sulfide; Sulindac sulfide lactone

Indexed keywords

INDOMETACIN; LACTONE DERIVATIVE; SULINDAC SULFIDE; SULINDAC SULFIDE LACTONE; TRIETHYLAMINE; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; LACTONIZATION; PUMMERER REACTION; REACTION ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 79951512104     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2011.01.008     Document Type: Article

References (18)

1. K.V.S. Nemmani, S.V. Mali, N. Borhade, A.R. Pathan, M. Karwa, V. Pamidiboina, S.P. SenthilKumar, M. Gund, A.K. Jain, N.K. Mangu, N.P. Dubash, D. Desai, S. Sharma, and A. Satyam Bioorg. Med. Chem. Lett. 19 2009 5297
2. A.R. Pathan, M. Karwa, V. Pamidiboina, J.J. Deshattiwar, N.J. Deshmukh, P.P. Gaikwad, S.V. Mali, D.C. Desai, M. Dhiman, T.T. Mariappan, S.D. Sharma, A. Satyam, and K.V.S. Nemmani Inflammopharmacol. 18 2010 157
3. Official FDA Information on sulindac at www.drugs.com.
4. We sincerely thank the reviewer for giving useful comments and suggestions on the mechanism of this unique transformation.
5. L.H.S. Smith, S.C. Coote, H.F. Sneddon, and D. Procter J. Angew. Chem., Int. Ed. 49 2010 5832
6. S.K. Bur, and A. Padwa Chem. Rev. 104 2004 2401
7. K.S. Feldman Tetrahedron 62 2006 5003
8. S. Akai, and Y. Kita Top. Curr. Chem. 274 2007 35
9. K.S. Feldman, and A.Y. Nuriye Tetrahedron Lett 50 2009 1914
10. K.S. Feldman, and A.G. Karatjas Org. Lett. 8 2006 4137
11. K.S. Feldman, and M.D. Fodor J. Am. Chem. Soc. 130 2008 14964
12. G. Xu, K. Chen, and H. Zhou Synthesis 2009 3565
13. J. Liu, M. Wang, B. Li, Q. Liu, and Y. Zhao J. Org. Chem. 72 2007 4401
14. G.J. Sperl, R. Pamukcu, K. Brendel, and P.H. Gross J. Labelled Compd. Radiopharm. 42 1999 877
15. 2S, unit cell parameters a 7.317(5) b 18.346(5) c 12.347(5), α 90, β 107.07(5), γ 90, space group P21/a monoclinic, CCDC No. 742703. Synthesis of (E)-ethyl 2-((Z)-6-fluoro-2-methyl-3-(4-(methylthio)benzylidene)- 2,3-dihydro-1H-inden-1-ylidene)acetate (Sulindac sulfide ethyl ester) (10): Sulindac sulfide 5 (50 mg, 0.147 mmol) was dissolved in dichloromethane (5 mL) by warming on a hot water bath. Oxalyl chloride (0.018 mL, 0.20 mmol) was added at room temperature under nitrogen and the reaction mixture was stirred for 2 h. The solvent was removed under reduced pressure. The crude material was re-dissolved in dichloromethane (5 mL) and a solution of absolute EtOH (0.012 mL, 0.20 mmol) and triethylamine (0.028 mL, 0.20 mmol) in dichloromethane (2 mL) was added drop-wise.
16. V.B. Cattani, L.A. Fiel, A. Jäger, E. Jäger, L.M. Colomé, F. Uchoa, V. Stefani, T.D. Costa, S.S. Guterres, and A.R. Pohlmann Eur. J. Pharm. Sci. 39 2010 116
17. Gross, P.; Sperl, G.; Pamukcu, R.; Brendel, K. U.S. Patent 5776,962
18. 1998; Chem. Abstr. 1998, 129, 122563.